Index
RUT
P/E
-
EPS (ttm)
-0.60
Insider Own
4.92%
Shs Outstand
164.42M
Perf Week
19.19%
Market Cap
1.54B
Forward P/E
-
EPS next Y
-0.19
Insider Trans
0.00%
Shs Float
154.92M
Perf Month
12.18%
Enterprise Value
1.04B
PEG
-
EPS next Q
-0.37
Inst Own
68.08%
Perf Quarter
20.02%
Income
-87.83M
P/S
2.58
EPS this Y
-117.34%
Inst Trans
2.66%
Perf Half Y
25.77%
Sales
596.34M
P/B
-
EPS next Y
57.21%
ROA
-7.52%
Perf YTD
40.56%
Book/sh
-0.88
P/C
1.95
EPS next 5Y
-
ROE
-
52W High
11.97 -21.09%
Perf Year
58.75%
Cash/sh
4.85
P/FCF
-
EPS past 3/5Y
- -
ROIC
-59.27%
52W Low
5.80 62.85%
Perf 3Y
22.51%
EV/EBITDA
17.53
Sales past 3/5Y
-17.24% 18.76%
Gross Margin
84.92%
Volatility
6.22% 4.55%
Perf 5Y
-94.63%
EV/Sales
1.75
EPS Y/Y TTM
323.82%
Oper. Margin
6.24%
ATR (14)
0.50
Perf 10Y
-89.76%
Quick Ratio
2.45
Sales Y/Y TTM
-52.48%
Profit Margin
-14.73%
RSI (14)
65.33
Current Ratio
2.48
EPS Q/Q
-101.99%
SMA20
12.69%
Beta
2.37
Debt/Eq
-
Sales Q/Q
-79.07%
SMA50
4.56%
Rel Volume
2.92
Prev Close
9.36
Employees
749
LT Debt/Eq
-
SMA200
14.78%
Avg Volume
4.27M
Price
9.45
IPO
Dec 05, 1995
Option/Short
Yes / Yes
Trades
Volume
5,211,295
Change
0.91%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-24-25 Resumed
Cantor Fitzgerald
Overweight
$18
Aug-28-25 Resumed
H.C. Wainwright
Buy
$10
Aug-20-25 Downgrade
BofA Securities
Neutral → Underperform
$7
Jun-17-25 Initiated
Citigroup
Sell
$6
Feb-28-25 Initiated
BTIG Research
Buy
$19
Jul-30-24 Downgrade
JP Morgan
Neutral → Underweight
$8
May-10-24 Upgrade
JP Morgan
Underweight → Neutral
May-10-24 Upgrade
BofA Securities
Underperform → Neutral
$4 → $12
Aug-09-23 Upgrade
B. Riley Securities
Neutral → Buy
$15
Apr-20-23 Downgrade
TD Cowen
Outperform → Market Perform
$55 → $10
Mar-01-23 Downgrade
B. Riley Securities
Buy → Neutral
$29 → $10
Jan-09-23 Reiterated
B. Riley Securities
Buy
$74 → $37
Dec-30-22 Reiterated
H.C. Wainwright
Buy
$207 → $110
Dec-02-22 Initiated
Jefferies
Hold
Sep-22-22 Downgrade
JP Morgan
Neutral → Underweight
$132 → $27
May-20-22 Initiated
BofA Securities
Underperform
$35
Feb-23-22 Reiterated
B. Riley Securities
Buy
$315 → $265
Feb-22-22 Resumed
Jefferies
Buy
$198
Jan-21-22 Initiated
Cowen
Outperform
$150
May-12-21 Downgrade
JP Morgan
Overweight → Neutral
$285 → $161
Show Previous Ratings
May-06-26 04:50PM
08:08AM
08:00AM
Apr-29-26 04:00PM
Apr-08-26 07:49AM
08:00AM
Loading…
Mar-30-26 08:00AM
Mar-03-26 09:00AM
Feb-27-26 02:20PM
12:40PM
08:26AM
06:43AM
01:54AM
(New feeds test provider finance)
12:31AM
12:07AM
Feb-26-26 04:30PM
04:11PM
Loading…
04:11PM
03:55PM
02:19PM
12:15PM
12:10PM
08:46AM
08:17AM
(Associated Press Finance)
08:06AM
08:00AM
Feb-25-26 06:09AM
Feb-23-26 12:00PM
10:33AM
09:07AM
Feb-19-26 08:00AM
Feb-17-26 09:00AM
05:45PM
Loading…
Feb-11-26 05:45PM
Feb-06-26 09:00AM
Feb-03-26 05:45PM
Jan-31-26 07:58AM
Jan-29-26 08:50AM
Jan-28-26 05:45PM
03:00AM
Jan-26-26 12:16PM
09:00AM
Jan-22-26 05:45PM
01:03AM
Jan-21-26 03:40PM
10:06AM
07:25AM
(Pharmaceutical Technology)
05:38AM
Jan-20-26 12:53PM
10:42AM
09:59AM
(The Wall Street Journal)
07:15AM
Jan-15-26 06:19PM
(Pharmaceutical Technology)
-5.01%
Jan-14-26 05:45PM
08:19AM
Jan-13-26 03:23PM
09:00AM
Jan-12-26 11:27AM
Jan-07-26 08:00AM
Jan-05-26 05:45PM
Jan-04-26 10:39PM
Jan-02-26 11:01AM
Jan-01-26 05:43PM
Dec-30-25 09:00AM
Dec-19-25 09:00AM
Dec-11-25 01:01PM
Dec-08-25 09:00AM
Dec-05-25 05:05PM
Dec-02-25 09:40AM
Dec-01-25 04:41PM
(Investor's Business Daily)
-5.11%
03:05PM
12:24PM
12:09PM
11:05AM
10:27AM
(The Wall Street Journal)
10:09AM
(Investor's Business Daily)
09:59AM
09:36AM
07:34AM
Nov-25-25 09:00AM
08:39AM
Nov-21-25 07:45PM
Nov-12-25 08:00AM
Nov-11-25 09:00AM
Nov-07-25 11:27AM
12:15AM
Nov-06-25 09:15AM
09:01AM
08:19AM
(Associated Press Finance)
08:00AM
Nov-05-25 08:25AM
Nov-04-25 07:00AM
Oct-30-25 08:00AM
Oct-29-25 11:57AM
Oct-28-25 05:45PM
Oct-24-25 06:16PM
09:34AM
07:09AM
Oct-22-25 05:45PM
07:00AM
Oct-21-25 09:00AM
Oct-16-25 05:45PM
Oct-14-25 01:33PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Newton Charles W. Director Apr 25 '26 Option Exercise 0.00 9,520 0 9,520 Apr 28 05:00 PM Shiver John W. Director Mar 10 '26 Option Exercise 0.00 7,947 0 7,947 Mar 12 05:00 PM Kelly James Patrick EVP, CFO and Treasurer Mar 07 '26 Option Exercise 0.00 12,223 0 136,503 Mar 09 06:13 PM Kelly James Patrick EVP, CFO and Treasurer Mar 03 '26 Option Exercise 0.00 43,167 0 145,130 Mar 05 06:04 AM Jacobs John C President and CEO Mar 03 '26 Option Exercise 0.00 150,167 0 264,130 Mar 05 06:03 AM O'Hara Elaine EVP, Chief Strategy Officer Mar 03 '26 Option Exercise 0.00 56,334 0 157,071 Mar 05 06:02 AM Casey Mark J EVP, Chief Legal Officer Mar 03 '26 Option Exercise 0.00 37,500 0 101,445 Mar 05 06:01 AM Draghia-Akli Ruxandra EVP, Research & Development Mar 03 '26 Option Exercise 0.00 26,667 0 34,876 Mar 05 06:00 AM Jacobs John C President and CEO Mar 01 '26 Option Exercise 0.00 83,333 0 264,130 Mar 03 09:37 PM Kelly James Patrick EVP, CFO and Treasurer Mar 01 '26 Option Exercise 0.00 58,666 0 130,299 Mar 03 09:35 PM O'Hara Elaine EVP, Chief Strategy Officer Mar 01 '26 Option Exercise 0.00 59,600 0 111,706 Mar 03 09:34 PM Casey Mark J EVP, Chief Legal Officer Mar 01 '26 Option Exercise 0.00 4,000 0 65,159 Mar 03 09:33 PM Jacobs John C President and CEO Jan 23 '26 Option Exercise 0.00 83,197 0 219,929 Jan 26 07:57 PM Casey Mark J EVP, Chief Legal Officer Dec 11 '25 Option Exercise 0.00 41,899 0 73,972 Dec 15 04:01 PM Draghia-Akli Ruxandra Section 16 Nov 11 '25 Option Exercise 0.00 14,257 0 14,257 Nov 13 05:23 PM MCGLYNN MARGARET G Director Jun 12 '25 Option Exercise 0.00 10,420 0 25,588 Jun 16 04:10 PM Alton Gregg H Director Jun 12 '25 Option Exercise 0.00 10,420 0 28,805 Jun 16 04:09 PM King Rachel K. Director Jun 12 '25 Option Exercise 0.00 10,420 0 25,190 Jun 13 09:41 PM Rodgers Richard J Director Jun 12 '25 Option Exercise 0.00 10,420 0 24,690 Jun 13 09:40 PM MOTT DAVID M Director Jun 12 '25 Option Exercise 0.00 10,420 0 60,890 Jun 13 09:39 PM DOUGLAS RICHARD Director Jun 12 '25 Option Exercise 0.00 10,420 0 54,340 Jun 13 09:36 PM YOUNG JAMES F Former Director May 19 '25 Proposed Sale 7.59 10,000 75,883 May 19 04:37 PM